The results obtained revealed that MDM2 was more highly expressed in stem cells (expressing the stem cell marker SOX2) than in non-stem cells (not expressing SOX2) in all three pairs of the glioma stem cell line and its non-stem cell counterpart examined (Figure 1A). This evidence concerns the gene SOX2 and central nervous system cancer.